Nitric oxide decreases surfactant protein gene expression in primary cultures of type II pneumocytes

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 288, Issue 5 32-5, 2005, Pages

  Lee, Jae W ^a   Gonzalez, Robert F ^a   Chapin, Cheryl J ^a   Busch, Justin ^b   Fineman, Jeffrey E ^a,b   Gutierrez, Jorge A ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelin 1; Extracellular signal regulated kinase 1 2

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; BOSENTAN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE; NITRIC OXIDE DONOR; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; SURFACTANT PROTEIN C;

ANIMAL CELL; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONGENITAL HEART DISEASE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; LUNG ALVEOLUS CELL TYPE 2; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; PULMONARY HYPERTENSION; RAT; RECEPTOR BLOCKING; VASODILATATION;

ANIMALS; BUTADIENES; CELLS, CULTURED; ENDOTHELIN-1; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; IMMUNOBLOTTING; MALE; MAP KINASE SIGNALING SYSTEM; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRILES; PENICILLAMINE; PULMONARY ALVEOLI; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; PULMONARY SURFACTANT-ASSOCIATED PROTEIN C; PULMONARY SURFACTANT-ASSOCIATED PROTEINS; RATS; RNA, MESSENGER; SPECIFIC PATHOGEN-FREE ORGANISMS;

EID: 17444421124     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.00210.2004     Document Type: Article

References (61)

1. Akassoglou K, Yu WM, Akpinar P, and Strickland S. Fibrin inhibits peripheral nerve remyelination by regulating schwann cell differentiation. Neuron 33: 861-875, 2002.
2. Ayad O and Wong HR. Nitric oxide decreases surfactant protein A gene expression in H441 cells. Crit Care Med 26: 1277-1282, 1998.
3. Bates SR, Gonzales LW, Tao J, Rueckert P, Ballard PL, and Fisher AB. Recovery of rat type II cell surfactant components during primary cell culture. Am J Physiol Lung Cell Mol Physiol 282: L267-L276, 2002.
4. Bhandari V, Johnson L, Smith-Kirwin S, Vigliotta G, Funanage V, and Chander A. Hyperoxia and nitric oxide reduce surfactant components (DSPC and surfactant proteins) and increase apoptosis in adult and fetal rat type II pneumocytes. Lung 180: 301-317, 2002.
5. Black SM, Bekker JM, Johengen MJ, Parry AJ, Soifer SJ, and Fineman JR. Altered regulation of the ET-1 cascade in lambs with increased pulmonary blood flow and pulmonary hypertension. Pediatr Res 47: 97-106, 2000.
6. Black SM, Fineman JR, Steinhorn RH, Bristow J, and Soifer SJ. Increased endothelial NOS in lambs with increased pulmonary blood flow and pulmonary hypertension. Am J Physiol Heart Circ Physiol 275: H1643-H1651, 1998.
7. Boulanger C and Luscher TF. Release of endothelin from the porcine aorta. Inhibition by endothelin-derived nitric oxide. J Clin Invest 85: 587-590, 1990.
8. Burrows FA, Klinck JR, Rabinovitch M, and Bohn DJ. Pulmonary hypertension in children: perioperative management. Can Anaesth Soc J 33: 606-628, 1986.
9. Camps M, Nichols A, and Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase formation. FASEB J 14: 6-16, 1999.
10. Clark RH, Kueser TJ, Walker MW, Southgate WM, Huckaby JL, Perez JA, Roy BJ, Keszler M, and Kinsella JP. Low-dose nitric oxide therapy for persistent pulmonary hypertension of the newborn. Clinical inhaled nitric oxide research group. N Engl J Med 336: 597-604, 1997.
11. Clozel M, Breu V, Gray GA, Kalina B, Loffler BM, Burri K, Cassal JM, Hirth G, Muller M, Neidhart W, and Ramuz H. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist. J Pharmacol Exp Ther 270: 228-235, 1994.
12. Davenport AP. International union of pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54: 219-226, 2002.
13. Dinger J, Topfer A, Schaller P, and Schwarze R. Functional residual capacity and compliance of the respiratory system after surfactant treatment in premature infants with severe respiratory distress syndrome. Eur J Pediatr 161: 485-490, 2002.
14. Dobbs LG. Isolation and culture of alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 258: L134-L147, 1990.
15. Dobbs LG and Gonzalez RF. Isolation and culture of pulmonary alveolar epithelial type II cells. In: Culture of Epithelial Cells (2nd ed.), edited by Freshney IR and Freshney MG. New York: Wiley-Liss, 2002, p. 277-301.
16. Dobbs L, Gonzales R, and Williams MC. An improved method for isolating type II cells in high purity and yield. Am Rev Respir Dis 134: 141-145, 1986.
17. Dobbs LG, Pian MS, Maglio M, Dumars S, and Allen L. Maintenance of the differentiated type II cell phenotype by culture with an apical air surface. Am J Physiol Lung Cell Mol Physiol 273: L347-L354, 1997.
18. Dobbs LG, Williams MC, and Gonzalez R. Monoclonal antibodies specific to apical surfaces of rat alveolar type I cells bind to surfaces of cultured, but not freshly isolated, type II cells. Biochim Biophys Acta 970: 146-156, 1988.
19. Goirand F, Bardou M, Guerard P, Dumas JP, Rochette L, and Dumas M. ETA, mixed ETA/ETB receptor antagonists, and protein kinase c inhibitor prevent acute hypoxic pulmonary vasoconstriction:influence of potassium channels. J Cardiovasc Pharmacol 41: 117-125, 2003.
20. Gonzalez R and Dobbs LG. Characterization and utility of a monoclonal antibody specific to the apical surface of rat alveolar type II cells (Abstract). Mol Biol Cell 8: 1981, 1997.
21. Gonzalez RF, Gutierrez JA, and Dobbs LG. Cultured Type I cells display phenotypic plasticity (Abstract). Am J Respir Crit Care Med 167: C63, 2004.
22. Gutierrez JA, Gonzalez RF, and Dobbs LG. Mechanical distention modulates pulmonary alveolar epithelial phenotypic expression in vitro. Am J Physiol Lung Cell Mol Physiol 274: L196-L202, 1998.
23. Gutierrez JA, Parry AJ, McMullan DM, Chapin CJ, and Fineman JR. Decreased surfactant proteins in lambs with pulmonary hypertension secondary to increased blood flow. Am J Physiol Lung Cell Mol Physiol 281: L1264-L1270, 2001.
24. Gutierrez JA, Suzara VV, and Dobbs LG. Continuous mechanical contraction modulates expression of alveolar epithelial cell phenotype. Am J Respir Cell Mol Biol 29: 81-87, 2003.
25. Haddad IY, Crow JP, Hu P, Ye Y, Beckman J, and Matalon S. Concurrent generation of nitric oxide and superoxide damages surfactant protein A. Am J Physiol Lung Cell Mol Physiol 267: L242-L249, 1994.
26. Haddad IY, Ischiropoulos H, Holm BA, Beckman JS, Baker JR, and Matalon S. Mechanisms of peroxynitrite-induced injury to pulmonary surfactant. Am J Physiol Lung Cell Mol Physiol 265: L555-L564, 1993.
27. Haddad IY, Zhu S, Crow J, Barefield E, Gadilhe T, and Matalon S. Inhibition of alveolar type II cell ATP and surfactant synthesis by nitric oxide. Am J Physiol Lung Cell Mol Physiol 270: L898-L906, 1996.
28. Haddad IY, Zhu S, Ischiropoulos H, and Matalon S. Nitration of surfactant protein A results in decreased ability to aggregate lipids. Am J Physiol Lung Cell Mol Physiol 270: L281-L288, 1996.
29. Hallman M and Bry K. Nitric oxide and surfactant. Semin Perinatal 20: 173-185, 1996.
30. Hallman M, Bry K, and Lappalainen U. A mechanism of nitric oxide-induced surfactant dysfunction. J Appl Physiol 80: 2035-2043, 1996.
31. Hallman M, Haataja R, and Marttila R. Surfactant proteins and genetic predisposition to respiratory distress syndrome. Semin Perinatol 26: 450-460, 2002.
32. Hallman M, Waffarn F, Bry K, Turbow R, Kleinman MT, Mautz WJ, Rasmussen RE, Bhalla DK, and Phalen RF. Surfactant dysfunction after inhalation of nitric oxide. J Appl Physiol 80: 2026-2034, 1996.
33. Jacob A, Molkentin JD, Smolenski A, Lohmann SM, and Begum N. Insulin inhibits PDGF-directed VSMC migration via NO/cGMP increase of MKP-1 and its inactivation of MAPKs. Am J Physiol Cell Physiol 283: C704-C713, 2002.
34. Kelly LK, Wedgewood S, Steinhorn RH, and Black SM. Nitric oxide decreases endothelin-1 secretion through the activation of soluble guanylate cyclase. Am J Physiol Lung Cell Mol Physiol 286: L984-L991, 2004.
35. Kitterman JA, Chapin CJ, Vanderbilt JN, Porta NFM, Scavo LM, Dobbs LG, Ertsey R, and Goerke J. Effects of oligohydramnios on lung growth and maturation in the fetal lung. Am J Physiol Lung Cell Mol Physiol 282: L431-L439, 2002.
36. Kumar S, Boehm J, and Lee JC. P38 MAP kinases: key signaling molecules as therapeutic targets for inflammatory diseases. Nat Rev Drug Discov 2: 717-726, 2003.
37. Lee JW, Ovadia B, Azakie A, Salas S, Goerke J, Fineman JR, and Gutierrez JA. Increased pulmonary blood flow does not alter surfactant protein gene expression in lambs within the first week of life. Am J Physiol Lung Cell Mol Physiol 286: L1237-L1243, 2004.
38. Lopez-Ongil S, Senchak V, Saura M, Zaragoza C, Ames M, Ballermann B, Rodriguez-Puyol M, Rodriguez-Puyol D, and Lowenstein CJ. Superoxide regulation of endothelin-converting enzyme. J Biol Chem 275: 26423-26427, 2000.
39. Maguire JJ, Kuo RE, and Davenport AP. Affinity and selectivity of PD156707, a novel nonpeptide endothelin antagonist, for human ETA and ETB receptors. J Pharmacol Exp Ther 280: 1102-1108, 1997.
40. Maguire JJ, Yu JCM, and Davenport AP. ETA receptor antagonists inhibit intimai smooth muscle cell proliferation in human vessels. Clin Sci 103: 184S-188S, 2002.
41. Mason RJ, Lewis MC, Edeen KE, McCormick-Shannon K, Nielsen LD, and Shannon JM. Maintenance of surfactant protein A and D secretion by rat alveolar type II cells in vitro. Am J Physiol Lung Cell Mol Physiol 282: L249-L258, 2002.
42. Matalon S, DeMarco V, Haddad IY, Myles C, Skimming JW, Schurch S, Cheng S, and Cassin S. Inhaled nitric oxide injures the pulmonary surfactant system of lambs in vivo. Am J Physiol Lung Cell Mol Physiol 270: L273-L280, 1996.
43. Miller OI, Tang SF, Keech A, Pigott NB, Beller E, and Celermajer DS. Inhaled nitric oxide and prevention of pulmonary hypertension after congenital heart surgery: a randomized double-blind study. Lancet 356: 1464-1469, 2000.
44. Monteiro HP, Gruia-Gray J, Peranovich TMS, Barbosa De Oliveira LC, and Stern A. Nitric oxide stimulates tyrosine phosphorylation of focal adhesion kinase, SRC kinase, and mitogen-activated protein kinases in murine fibroblasts. Free Radic Biol Med 28: 174-182, 2000.
45. Muller B, Schafer H, Barth P, and von Wichert P. Lung surfactant components in bronchoalveolar lavage after inhalation of NO2 as markers of altered surfactant metabolism. Lung 172: 61-72, 1994.
46. Oliveira CJR, Schindler F, Ventura AM, Morais MS, Arai RJ, Debbas V, Stern A, and Monteiro HP. Nitric oxide and cGMP activate the Ras-MAP kinase pathway-stimulating protein tyrosine phosphorylation in rabbit aortic endothelial cells. Free Radic Biol Med 35: 381-396, 2003.
47. Ovadia B, Reinhartz O, Fitzgerald R, Bekker JM, Johengen MJ, Azakie A, Thelitz S, Black SM, and Fineman JR. Alterations in ET-1, not nitric oxide, in 1-week-old lambs with increased pulmonary blood flow. Am J Physiol Heart Circ Physiol 284: H480-H490, 2003.
48. Peduto Eberl L, Bovey R, and Juillerat-Jeanneret L. Endothelin-receptor antagonists are proapoptotic and antiproliferative in human colon cancer cells. Br J Cancer 88: 788-795, 2003.
49. Pervin S, Singh R, Freije WA, and Chaudhuri G. MKP-1-induced dephosphorylation of extracellular signal-regulated kinase is essential for triggering nitric oxide-induced apoptosis in human breast cancer cell lines: implications in breast cancer. Cancer Res 63: 8853-8860, 2003.
50. Roberts JD Jr, Fineman JR, Morin FC III, Shaul PW, Rimar S, Schreiber MD, Polin RA, Zwass MS, Zayek MM, Gross I, Heymann MA, and Zapol WM. Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The inhaled nitric oxide study group. N Engl J Med 336: 605-610, 1997.
51. Rubin LJ and Roux S. Bosentan: a dual endothelin receptor antagonist. Expert Opin Investig Drugs 11: 991-1002, 2002.
52. Salinas D, Sparkman L, Berhane K, and Boggaram V. Nitric oxide inhibits surfactant protein B gene expression in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 285: L1153-L1165, 2003.
53. Sen N, Grunstein MN, and Chander A. Stimulation of lung surfactant secretion by endothelin-1 from rat alveolar type II cells. Am J Physiol Lung Cell Mol Physiol 266: L255-L262, 1994.
54. Shannon JM, Emrie PA, Fisher JH, Kuroki Y, Jennings SD, and Mason RJ. Effect of a reconstituted basement membrane on expression of surfactant apoproteins in cultured adult rat alveolar type II cells. Am J Respir Cell Mol Biol 2: 183-192, 1990.
55. Shannon JM, Pan T, Nielsen LD, Edeen KE, and Mason RJ. Lung fibroblasts improve differentiation of rat type II cells in primary culture. Am J Respir Cell Mol Biol 24: 235-244, 2001.
56. Shima H, Oue T, Taira Y, Miyazaki E, and Puri P. Antenatal dexamethasone enhances endothelin receptor B expression in hypoplastic lung in nitrofen-induced diaphragmatic hernia in rats. J Pediatr Surg 35: 203-207, 2000.
57. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, and Klenk DC. Measurement of protein using bicinchoninic acid. Anal Biochem 150: 76-85, 1985.
58. Stuart RB, Ovadia B, Suzara VV, Ross PA, Thelitz S, Fineman JR, and Gutierrez JA. Inhaled nitric oxide increases surfactant protein gene expression in the intact lamb. Am J Physiol Lung Cell Mol Physiol 285: L628-L633, 2003.
59. Vogt A, Adachi T, Ducruet AP, Chesebrough J, Nemoto K, Carr BI, and Lazo JS. Spatial analysis of key signaling proteins by high-content solid-phase cytometry in Hep3B cells treated with an inhibitor of cdc25 dual-specificity phosphatases. J Biol Chem 276: 20544-20550, 2001.
60. Yano T, Mason RJ, Pan T, Deterding RR, Nielsen LD, and Shannon JM. KGF regulates pulmonary epithelial proliferation and surfactant protein gene expression in adult rat lung. Am J Physiol Lung Cell Mol Physiol 279: L1146-L1158, 2000.
61. Zou MH, Shi C, and Cohen RA. Oxidation of zinc-thiolate complex and uncoupling of endothelial nitric oxide synthase by peroxynitrite. J Clin Invest 109:817-826, 2002.